Oncocyte (NYSE American:OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:20PM PST / 3:20PM EST.
September 1, 2020
· 2 min read